Trademark: 90459476
Word
POWERING THE FUTURE OF IMMUNE MEDICINE.
Status Date
Monday, June 5, 2023
Filing Date
Monday, January 11, 2021
Published for Opposition
Tuesday, September 7, 2021
Abandoned Date
Monday, June 5, 2023
44 Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; consulting services in the field of medical diagnostic and prognostic testing; medical analysis services for diagnostic and prognostic testing and treatment purposes; providing medical diagnostic and prognostic testing services; Medical analysis services relating to the diagnosis and treatment of person
42 Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services
Jun 5, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 5, 2023
Abandonment - No Use Statement Filed
Nov 4, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 2, 2022
Sou Extension 2 Granted
Nov 2, 2022
Sou Extension 2 Filed
Nov 2, 2022
Sou Teas Extension Received
May 4, 2022
Notice Of Approval Of Extension Request E-Mailed
May 2, 2022
Sou Extension 1 Granted
May 2, 2022
Sou Extension 1 Filed
May 2, 2022
Sou Teas Extension Received
Nov 2, 2021
Noa E-Mailed - Sou Required From Applicant
Sep 7, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 7, 2021
Published For Opposition
Aug 18, 2021
Notification Of Notice Of Publication E-Mailed
Aug 2, 2021
Approved For Pub - Principal Register
Jul 28, 2021
Examiner's Amendment Entered
Jul 28, 2021
Notification Of Examiners Amendment E-Mailed
Jul 28, 2021
Examiners Amendment E-Mailed
Jul 28, 2021
Examiners Amendment -Written
Jul 20, 2021
Assigned To Examiner
Apr 11, 2021
New Application Office Supplied Data Entered
Jan 14, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
